JPS5883041A - 樹脂組成物 - Google Patents

樹脂組成物

Info

Publication number: JPS5883041A
Authority: JP; Japan
Prior art keywords: maleic anhydride; copolymer; component; vinyl; resin composition
Prior art date: 1981-11-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP56180681A

Other languages

English (en)

Japanese (ja)

Other versions

JPH0128777B2 (fr

Inventor

Izumi Sakamoto

阪本　泉

Yoshihiro Umemura

梅村　吉弘

Tsukasa Uniki

雲丹亀　司

Kunihiko Takagi

邦彦高木

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Unitika Ltd

Original Assignee

Unitika Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-11-10

Filing date

1981-11-10

Publication date

1983-05-18

1981-11-10 Application filed by Unitika Ltd filed Critical Unitika Ltd

1981-11-10 Priority to JP56180681A priority Critical patent/JPS5883041A/ja

1983-05-18 Publication of JPS5883041A publication Critical patent/JPS5883041A/ja

1989-06-05 Publication of JPH0128777B2 publication Critical patent/JPH0128777B2/ja

Status Granted legal-status Critical Current

Links

239000011342 resin composition Substances 0.000 title claims description 22
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims abstract description 21
229920001577 copolymer Polymers 0.000 claims abstract description 19
239000000178 monomer Substances 0.000 claims abstract description 13
229920002554 vinyl polymer Polymers 0.000 claims abstract description 8
JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims abstract description 6
150000001336 alkenes Chemical class 0.000 claims abstract description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 24
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 22
238000002156 mixing Methods 0.000 abstract description 14
-1 antibodies Proteins 0.000 abstract description 8
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 abstract description 6
230000003100 immobilizing effect Effects 0.000 abstract description 6
239000002904 solvent Substances 0.000 abstract description 5
229920005989 resin Polymers 0.000 abstract description 4
239000011347 resin Substances 0.000 abstract description 4
108090000790 Enzymes Proteins 0.000 abstract description 3
102000004190 Enzymes Human genes 0.000 abstract description 3
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract description 3
239000005977 Ethylene Substances 0.000 abstract description 3
239000000427 antigen Substances 0.000 abstract description 3
102000036639 antigens Human genes 0.000 abstract description 3
108091007433 antigens Proteins 0.000 abstract description 3
XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 abstract description 3
XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 abstract description 2
QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 abstract description 2
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 3
230000002070 germicidal effect Effects 0.000 abstract 1
229920001567 vinyl ester resin Polymers 0.000 abstract 1
239000013543 active substance Substances 0.000 description 19
238000000034 method Methods 0.000 description 16
239000000243 solution Substances 0.000 description 13
230000000694 effects Effects 0.000 description 10
238000007334 copolymerization reaction Methods 0.000 description 6
239000000203 mixture Substances 0.000 description 6
229920000642 polymer Polymers 0.000 description 6
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
230000000052 comparative effect Effects 0.000 description 5
UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 5
239000003960 organic solvent Substances 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 4
239000007787 solid Substances 0.000 description 4
238000009987 spinning Methods 0.000 description 4
ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
108010040201 Polymyxins Proteins 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
230000008901 benefit Effects 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000010839 body fluid Substances 0.000 description 3
239000000969 carrier Substances 0.000 description 3
238000004132 cross linking Methods 0.000 description 3
230000009257 reactivity Effects 0.000 description 3
108010093031 Galactosidases Proteins 0.000 description 2
102000002464 Galactosidases Human genes 0.000 description 2
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
239000004372 Polyvinyl alcohol Substances 0.000 description 2
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 2
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 2
150000001298 alcohols Chemical class 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
229940041181 antineoplastic drug Drugs 0.000 description 2
239000003899 bactericide agent Substances 0.000 description 2
HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000003431 cross linking reagent Substances 0.000 description 2
230000007423 decrease Effects 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
239000008187 granular material Substances 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
229960002897 heparin Drugs 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
239000000463 material Substances 0.000 description 2
229920005862 polyol Polymers 0.000 description 2
150000003077 polyols Chemical class 0.000 description 2
229920002451 polyvinyl alcohol Polymers 0.000 description 2
238000000926 separation method Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 2
229960005356 urokinase Drugs 0.000 description 2
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
FPSURBCYSCOZSE-UHFFFAOYSA-N 1-ethenoxybutan-1-ol Chemical compound CCCC(O)OC=C FPSURBCYSCOZSE-UHFFFAOYSA-N 0.000 description 1
HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010059892 Cellulase Proteins 0.000 description 1
235000006481 Colocasia esculenta Nutrition 0.000 description 1
240000004270 Colocasia esculenta var. antiquorum Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
229930182566 Gentamicin Natural products 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Polymers OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
108010059820 Polygalacturonase Proteins 0.000 description 1
108010093965 Polymyxin B Proteins 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000004220 aggregation Methods 0.000 description 1
230000002776 aggregation Effects 0.000 description 1
238000007605 air drying Methods 0.000 description 1
229960004821 amikacin Drugs 0.000 description 1
LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
150000001414 amino alcohols Chemical class 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
229960000686 benzalkonium chloride Drugs 0.000 description 1
229960001950 benzethonium chloride Drugs 0.000 description 1
UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
210000000476 body water Anatomy 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
238000005266 casting Methods 0.000 description 1
229940106157 cellulase Drugs 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000000151 deposition Methods 0.000 description 1
JJCQSGDBDPYCEO-XVZSLQNASA-N dibekacin Chemical compound O1[C@H](CN)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N JJCQSGDBDPYCEO-XVZSLQNASA-N 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000000578 dry spinning Methods 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
108010093305 exopolygalacturonase Proteins 0.000 description 1
239000000499 gel Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
229960002518 gentamicin Drugs 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
229920001519 homopolymer Polymers 0.000 description 1
229920001600 hydrophobic polymer Polymers 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000007654 immersion Methods 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
239000001573 invertase Substances 0.000 description 1
235000011073 invertase Nutrition 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
150000002576 ketones Chemical class 0.000 description 1
239000002184 metal Substances 0.000 description 1
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
229920005615 natural polymer Polymers 0.000 description 1
238000012856 packing Methods 0.000 description 1
QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920000768 polyamine Polymers 0.000 description 1
229920006267 polyester film Polymers 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
229920001228 polyisocyanate Polymers 0.000 description 1
239000005056 polyisocyanate Substances 0.000 description 1
229960003548 polymyxin b sulfate Drugs 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000005507 spraying Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
239000000126 substance Substances 0.000 description 1
125000001174 sulfone group Chemical group 0.000 description 1
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
VSRBKQFNFZQRBM-UHFFFAOYSA-N tuaminoheptane Chemical compound CCCCCC(C)N VSRBKQFNFZQRBM-UHFFFAOYSA-N 0.000 description 1
229960003986 tuaminoheptane Drugs 0.000 description 1
230000002747 voluntary effect Effects 0.000 description 1

Landscapes

Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Compositions Of Macromolecular Compounds (AREA)

JP56180681A 1981-11-10 1981-11-10 樹脂組成物 Granted JPS5883041A (ja)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
JP56180681A JPS5883041A (ja)	1981-11-10	1981-11-10	樹脂組成物

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP56180681A JPS5883041A (ja)	1981-11-10	1981-11-10	樹脂組成物

Publications (2)

Publication Number	Publication Date
JPS5883041A true JPS5883041A (ja)	1983-05-18
JPH0128777B2 JPH0128777B2 (fr)	1989-06-05

Family

ID=16087438

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP56180681A Granted JPS5883041A (ja)	1981-11-10	1981-11-10	樹脂組成物

Country Status (1)

Country	Link
JP (1)	JPS5883041A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101864408A (zh) *	2010-05-25	2010-10-20	中国科学院过程工程研究所	一种纳米纤维固定化β-D-半乳糖苷酶的制备方法

1981
- 1981-11-10 JP JP56180681A patent/JPS5883041A/ja active Granted

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101864408A (zh) *	2010-05-25	2010-10-20	中国科学院过程工程研究所	一种纳米纤维固定化β-D-半乳糖苷酶的制备方法

Also Published As

Publication number	Publication date
JPH0128777B2 (fr)	1989-06-05

Publication	Publication Date	Title
CA1338958C (fr)	1997-03-04	Matrices d'hydrogel biodegradables pour la liberation prolongee d'agents pharmacologiquement actifs
Kouchak et al.	2014	Chitosan and polyvinyl alcohol composite films containing nitrofurazone: preparation and evaluation
Kurisawa et al.	1998	Dual-stimuli-responsive drug release from interpenetrating polymer network-structured hydrogels of gelatin and dextran
Lancina III et al.	2017	Chitosan nanofibers for transbuccal insulin delivery
Park et al.	1992	Poly (L-lactic acid)/Pluronic blends: characterization of phase separation behavior, degradation, and morphology and use as protein-releasing matrixes
EP0164311B1 (fr)	1991-03-20	Dispositifs d'hydrogel contenant des substances actives dans lesquels le profil de concentration de la substance active contient un gradient de concentration sigmoidien pour une libération constante, leur fabrication et leur utilisation
Woźniak et al.	2022	Methods for crosslinking and stabilization of chitosan structures for potential medical applications
KR100478227B1 (ko)	2005-03-21	키틴 및/또는 키토산으로 구성되는 혈관 색전 물질의 제조방법
CN108939173B (zh)	2020-04-21	一种兼具抗炎及原位催化no持续释放的双功能心血管涂层材料及其制备方法
Zhang et al.	2004	Preparation and release behavior of carboxymethylated chitosan/alginate microspheres encapsulating bovine serum albumin
Thacharodi et al.	1993	Propranolol hydrochloride release behaviour of crosslinked chitosan membranes
JP2002524100A (ja)	2002-08-06	ポリマー固定生細胞、およびその利用
Verestiuc et al.	2006	Functionalized chitosan/NIPAM (HEMA) hybrid polymer networks as inserts for ocular drug delivery: Synthesis, in vitro assessment, and in vivo evaluation
Chiou et al.	2001	Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres
WO2020011240A1 (fr)	2020-01-16	Procédé de préparation d'un aérogel à base de cellulose à double sensibilité
Kan et al.	2005	Thermogelling emulsions for vascular embolization and sustained release of drugs
JPH03278835A (ja)	1991-12-10	発熱物質の吸着材料
Murugesan et al.	2006	Ionic liquid‐derived blood‐compatible composite membranes for kidney dialysis
Afzal et al.	2018	The structural, crystallinity, and thermal properties of pH-responsive interpenetrating gelatin/sodium alginate-based polymeric composites for the controlled delivery of cetirizine HCl
Asghar et al.	2018	Hydrophobic–hydrophilic cross‐linked matrices for controlled release formulation of highly water‐soluble drug venlafaxine: synthesis and evaluation studies
Zhang et al.	2021	Novel therapeutic platform of micelles and nanogels from dopa‐functionalized triblock copolymers
Şanlı et al.	2009	Preparation, characterization, and salicylic acid release behavior of chitosan/poly (vinyl alcohol) blend microspheres
Spizzirri et al.	2013	Temperature-sensitive hydrogels by graft polymerization of chitosan and N-isopropylacrylamide for drug release
JPS5883633A (ja)	1983-05-19	生理活性物質固定化用担体
JPH0128777B2 (fr)	1989-06-05

JPS5883041A - 樹脂組成物 - Google Patents

Info

Links

Landscapes

Priority Applications (1)

Applications Claiming Priority (1)

Publications (2)

Family

ID=16087438

Family Applications (1)

Country Status (1)

Cited By (1)

Cited By (1)

Also Published As

Similar Documents